Overview

Tranexamic Acid Effect in Pediatric

Status:
Not yet recruiting

Trial end date:
2024-12-01

Target enrollment:
0

Participant gender:
All

Summary

The study will compare mortality and blood transfusion amounts among severely polytraumatized pediatrics who did or did not receive tranexamic acid within 3 h of injury, based on Injury Severity Score (ISS) and indicators of coagulopathy and fibrinolysis.

Phase:

Early Phase 1

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Assiut University

Treatments:

Tranexamic Acid

Criteria

Inclusion Criteria:

1. ISS ≥ 16

2. age 2-18 years

3. both genders

4. polytraum a

Exclusion Criteria:

1. age < 2 OR >18 years

2. period from injury to admission >6 hours

3. ISS<16

4. comorbidity with bleeding disorder, malignancy.

5. Patients receiving anticoagulant drugs.